EZH2 and tropical spastic paraparesis: Thus, this study aimed to investigate whether EZH2 and EZH1/2 inhibitors can inhibit the proliferation of HTLV-1-infected cells derived from patients with HAM and the excessive immune response seen in HAM in vitro and to examine their potential as novel therapeutic agents for HAM.